Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VALIC Company I Large Capital Growth Fund (VLCGX)

13.97
Net Asset Value
+0.22%
1 Day
+13.30%
Year-to-Date
Overall Morningstar Rating
Large growth
Style or Category
No Load
Sales Expenses
0.75%
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks to provide long-term growth of capital. The fund seeks to meet its objective by investing, normally, at least 80% of its net assets in securities of large-cap companies. In complying with this 80% investment requirement, the fund will invest primarily in common stocks. Generally, large-cap companies will include companies whose market capitalizations, at the time of purchase, are equal to or greater than the market capitalization of the smallest company in the Russell 1000 ® Index during the most recent 12-month period.

Performance

1 month+1.46% 3 years+9.72%
3 months+7.23% 5 years+13.87%
1 year+15.49% Since inception+6.89%
Data through --

Peer Comparisonvs. Large growth

 VLCGXCategory
Performance 5-yr return+13.87%+14.80%
Expense ratio0.75%0.86%
Risk 5 year sharpe ratio1.221.27
Net assets$413.1M$1.2B
Average market cap$60.3B$108.1B
Average P/E26.627.0
Portfolio turnover24%24%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyVALIC
Fund manager & tenureJeffrey Constantino / 3 Years
Minimal initial investment$0.00
Minimum IRA investment--

Holdings

U.S. stock90.77%
International stock8.68%
Cash0.55%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Hardware 14.42%
Industrial materials 13.91%
Consumer service 12.22%
Healthcare 11.00%
Energy 10.72%
Top 10 Holdings
Portfolio weighting
GOOGL Google6.60%
ACN Accenture4.15%
V Visa3.19%
TMO Thermo Fisher Scientific Inc2.79%
CL Colgate-Palmolive2.74%
AAPL Apple2.65%
NKE Nike2.57%
EL Estee Lauder2.52%
ECL Ecolab Inc2.47%
ABT Abbott Laboratories2.34%